The key points here are that
I) the IND will be submitted this week and
II) the first patients will be dosed within a couple of weeks of the clinical hold being lifted.
The small delay notwithstanding, the company is moving along in a very professional manner. I have high hopes for Factor!
- Forums
- ASX - By Stock
- DLM
- Ann: Shareholder Update-FTT.AX
Ann: Shareholder Update-FTT.AX, page-2
Featured News
Add DLM (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online